ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CARE vs MS // ALTMAN Z-SCORE & DEBT/EQUITY

Carter Bankshares Inc. (NASDAQ) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: CARE 4 — MS 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CARE VS. MS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CARE MS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 7.50% 3.00% +4.50 CARE /roic <GO>
EV/EBITDA & P/E Valuation — 31.0x — TIE /valuation <GO>
Free Cash Flow Yield 4.80% -7.25% +12.05 CARE /fcf-yield <GO>
Operating Margin — 24.60% — TIE /operating-margins <GO>
Net Profit Margin 68.00% 20.20% +47.80 CARE /net-margins <GO>
Revenue Growth (YoY) 4.60% 5.50% -0.90 MS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.21% -2.21 MS /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 5/9 +1.00 CARE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.8 51.0 -5.20 MS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.04 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 19.6x 16.5x +3.10 MS /forward-pe <GO>
Enterprise Scale & Market Cap $662.5M $298.41B -$297.75B MS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CARE REV MS REV CARE GROSS % MS GROSS % CARE FCF MS FCF
FY 2025 $20.3M $0 — — $31.8M -$17.89B
FY 2024 $19.4M $0 — — $28.8M $1.36B
FY 2023 $17.3M $0 — — $46.7M -$33.54B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CARE // BETA —
MS // BETA 1.04